Cargando…
A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9
A novel Influenza A virus (subtype H7N9) emerged in spring 2013 and caused considerable mortality in zoonotically infected patients. To be prepared for potential pandemics, broadly effective and safe vaccines are crucial. Recombinant measles virus (MeV) encoding antigens of foreign pathogens constit...
Autores principales: | Hörner, Cindy, Fiedler, Anna H., Bodmer, Bianca S., Walz, Lisa, Scheuplein, Vivian A., Hutzler, Stefan, Matrosovich, Mikhail N., von Messling, Veronika, Mühlebach, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037405/ https://www.ncbi.nlm.nih.gov/pubmed/36964176 http://dx.doi.org/10.1038/s41541-023-00643-9 |
Ejemplares similares
-
Development of Recombinant Measles Virus-Based Vaccines
por: Mühlebach, Michael D., et al.
Publicado: (2016) -
Morbillivirus Experimental Animal Models: Measles Virus Pathogenesis Insights from Canine Distemper Virus
por: da Fontoura Budaszewski, Renata, et al.
Publicado: (2016) -
Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model
por: Bodmer, Bianca S., et al.
Publicado: (2018) -
Vaccine platform recombinant measles virus
por: Mühlebach, Michael D.
Publicado: (2017) -
Functional significance of the hemadsorption activity of influenza virus neuraminidase and its alteration in pandemic viruses
por: Uhlendorff, Jennifer, et al.
Publicado: (2009)